Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Cited by (1,015)

Items 701–800 of 1,015

1. Nanomaterial-based SERS sensing technology for biomedical application
   Zhicheng Huang, Amin Zhang, Qian Zhang, Daxiang Cui · 2019 · Journal of Materials Chemistry B
2. Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review
   Bin Yang, Xiaoyan Li, Tianyi Ren, Yiyu Yin · 2019 · Cell Death Discovery
3. How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed?
   Yoshihisa Kobayashi, Takayuki Fukui, Simon Ito, Noriyasu Usami, Shunzo Hatooka, Yasushi Yatabe, Tetsuya Mitsudomi · 2013 · Journal of Thoracic Oncology
4. Molecular sputum analysis for the diagnosis of lung cancer
   A J Hubers, Clemens Prinsen, Gabriella Sozzi, Birgit Ilja Lissenberg-Witte, Erik Thunnissen · 2013 · British Journal of Cancer
5. Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer
   Masatsugu Hamaji, Mark S. Allen, Stephen D. Cassivi, Claude C. Deschamps, Francis C. Nichols, Dennis A. Wigle, K. Robert Shen · 2013 · Journal of Thoracic and Cardiovascular Surgery
6. The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections
   Tim Byers, Richard C. Wender, Ahmedin Jemal, Arnold M. Baskies, Elizabeth E. Ward, Otis W. Brawley · 2016 · CA A Cancer Journal for Clinicians
7. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial
   Frank Sullivan, Eoghan C. W. Farmer, Frances S Mair, Shaun P. Treweek, Denise Kendrick, Cathy Jackson, Chris Robertson, Andrew H. Briggs, Colin McCowan, Laura Elizabeth Bedford et al. · 2017 · BMC Cancer
8. Patient navigation for lung cancer screening among current smokers in community health centers a randomized controlled trial
   Sanja Percac‐Lima, Jeffrey M. Ashburner, Nancy A. Rigotti, Elyse Richelle Park, Yuchiao Chang, Salome Kuchukhidze, Steven J. Atlas · 2018 · Cancer Medicine
9. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer
   Yao Tao, Yuting Tang, Zailin Yang, Futao Wu, Lu Wang, Liyuan Yang, Lei Li, Yipei Jing, Xueke Jiang, Hongjun Jin et al. · 2020 · International Journal of Biological Sciences
10. ROI-based feature learning for efficient true positive prediction using convolutional neural network for lung cancer diagnosis
    Supriya Suresh, Subaji Mohan · 2020 · Neural Computing and Applications
11. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer
    Yu Chen, Emory Zitello, Rui Guo, Youping Deng · 2021 · Clinical and Translational Medicine
12. Principles, effectiveness and caveats in screening for cancer
    Michael Bretthauer, Mette Kalager · 2012 · British journal of surgery
13. The changing landscape of phase I trials in oncology
    Kit Man Wong, Anna Capasso, Sabine Eckhardt · 2015 · Nature Reviews Clinical Oncology
14. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non–Small Cell Lung Cancer
    Aritoshi Hattori, Takeshi Matsunaga, Takuo Hayashi, Kazuya Takamochi, Shiaki Oh, Kenji Suzuki · 2017 · Journal of Thoracic Oncology
15. Lung cancer health disparities
    Bríd M. Ryan · 2018 · Carcinogenesis
16. Automated classification of benign and malignant cells from lung cytological images using deep convolutional neural network
    Atsushi Teramoto, Ayumi Yamada, Yuka Kiriyama, Tetsuya Tsukamoto, Ke Yan, Ling Zhang, Kazuyoshi Imaizumi, Kuniaki Saito, Hiroshi Fujita · 2019 · Informatics in Medicine Unlocked
17. A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies
    Kevin ten Haaf, Mehrad Bastani, Pianpian Cao, Jihyoun Jeon, Iakovos Toumazis, Summer S. Han, Sylvia K. Plevritis, Erik F. Blom, Chung Yin Kong, Martin Carl Tammemägi et al. · 2019 · JNCI Journal of the National Cancer Institute
18. The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
    Cláudia Freitas, Catarina Sousa, Francisco Machado, Mariana Serino, Vanessa Santos, Natália Alves Martins, Armando Teixeira, António Manuel Trigueiros da Silva Cunha, Tânia Pereira, Hélder P. Oliveira et al. · 2021 · Frontiers in Oncology
19. Convolutional auto-encoder for image denoising of ultra-low-dose CT
    Nishio, Mizuho, Nagashima, Chihiro, Hirabayashi, Saori, Ohnishi, Akinori, Sasaki, Kaori, Sagawa, Tomoyuki, Hamada, Masayuki, Yamashita, Tatsuo · 2017 · Heliyon
20. Principles of Cancer Screening
    Paul F. Pinsky · 2015 · Surgical Clinics of North America
21. Exosomal lipids for classifying early and late stage non-small cell lung cancer
    Teresa W.‐M. Fan, Xiaofei Zhang, Chi Wang, Ye Yang, Woo-Young Kang, Susanne M. Arnold, Richard M. Higashi, Jinze Liu, Andrew N. Lane · 2018 · Analytica Chimica Acta
22. Deep Learning in Medical Image Registration
    Chen, Xiang, Diaz-Pinto, Andres, Ravikumar, Nishant, Frangi, Alejandro · 2020 · Progress in Biomedical Engineering
23. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer
    Peilong Li, Shibiao Liu, Lutao Du, Ghazal Mohseni, Yi Zhang, Chuanxin Wang · 2022 · Clinical Epigenetics
24. Bronchus sign on thin-section computed tomography is a powerful predictive factor for successful transbronchial biopsy using endobronchial ultrasound with a guide sheath for small peripheral lung lesions: a retrospective observational study
    Tomoyuki Minezawa, Takuya Okamura, Hiroshi Yatsuya, Naoki Yamamoto, Sayako Morikawa, Teppei Yamaguchi, Mariko Morishita, Yoshikazu Niwa, Tomoko Takeyama, Yuki Mieno et al. · 2015 · BMC Medical Imaging
25. The association between baseline clinical–radiological characteristics and growth of pulmonary nodules with ground-glass opacity
    Yoshihisa Kobayashi, Yukinori Sakao, Gautam Anil Deshpande, Takayuki Fukui, Tetsuya Mizuno, Hiroaki Kuroda, Noriaki Sakakura, Noriyasu Usami, Yasushi Yatabe, Tetsuya Mitsudomi · 2013 · Lung Cancer
26. Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma
    Ignacio Ivan Wistuba, Carmen Behrens, Francesca Lombardi, Susanne Wagner, Junya Fujimoto, Maria Gabriela Raso, Lorenzo Spaggiari, Domenico Galetta, Robyn Riley, Elisha Hughes et al. · 2013 · Clinical Cancer Research
27. Lung cancer: Prevalent trends & emerging concepts
    Vinod Raina, Prabhat Singh Malik · 2015 · The Indian Journal of Medical Research
28. An automated lung segmentation approach using bidirectional chain codes to improve nodule detection accuracy
    Shiwen Shen, Alex A. T. Bui, Jason Cong, William W.Y. Hsu · 2014 · Computers in Biology and Medicine
29. Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
    Leonor Puchades‐Carrasco, Eloisa Jantus Lewintre, Clara Pérez-Rambla, Francisco Garcia‐García, Rut Lucas-Domínguez, Silvia Calabuig Fariñas, Ana Blasco, Joaquı́n Dopazo, Carlos Camps, Antonio Pineda‐Lucena · 2016 · Oncotarget
30. Screening for lung cancer: A systematic review and meta-analysis
    Muhammad Usman Ali, John Miller, Leslea Peirson, Donna Fitzpatrick‐Lewis, Meghan Kenny, Diana Sherifali, Parminder Raina · 2016 · Preventive Medicine
31. Image-guided techniques for localizing pulmonary nodules in thoracoscopic surgery
    Mong‐Wei Lin, Jin‐Shing Chen · 2016 · Journal of Thoracic Disease
32. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study
    Marjolein A. Heuvelmans, Joan Elias Walter, Robin Peters, Geertruida H. de Bock, Uraujh Yousaf-Khan, Carlijn M. van der Aalst, Harry J.M. Groen, Kristiaan Nackaerts, Peter M. A. van Ooijen, Harry J. de Koning et al. · 2017 · Lung Cancer
33. Understanding lung cancer screening behavior: Racial, gender, and geographic differences among Indiana long-term smokers
    Lisa Carter‐Harris, James E. Slaven, Patrick O. Monahan, Rivienne B. Shedd-Steele, Nasser H. Hanna, Susan M. Rawl · 2018 · Preventive Medicine Reports
34. Lung Cancer Screening Registry Reveals Low-dose CT Screening Remains Heavily Underutilized
    Danh Pham, Shruti Bhandari, Christina M. Pinkston, Malgorzata Oechsli, Goetz Hans Kloecker · 2019 · Clinical Lung Cancer
35. Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic review
    Eline Janssens, Jan P. van Meerbeeck, Kevin Lamote · 2020 · Critical Reviews in Oncology/Hematology
36. Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment
    Johannes Francois Fahrmann, Tracey L. Marsh, Ehsan Irajizad, Nikul J. Patel, Eunice N. Murage, Jody V. Vykoukal, Jennifer B. Dennison, Kim-Anh Do, Edwin Justin Ostrin, Margaret R. Spitz et al. · 2022 · Journal of Clinical Oncology
37. Pro–Surfactant Protein B As a Biomarker for Lung Cancer Prediction
    Don D. Sin, Martin Carl Tammemägi, Stephen C. Lam, Matt J. Barnett, Xiaobo Duan, Anthony Tam, Heidi J. Auman, Ziding Feng, Gary E. Goodman, Samir Hanash et al. · 2013 · Journal of Clinical Oncology
38. Analysis of MicroRNAs in Sputum to Improve Computed Tomography for Lung Cancer Diagnosis
    Jun Shen, Jipei Liao, Maria A. Guarnera, Hong‐Bin Fang, Ling Cai, Sanford A. Stass, Feng Jiang · 2013 · Journal of Thoracic Oncology
39. Small nucleolar RNA signatures of lung tumor-initiating cells
    Kaiissar Mannoor, Jun Shen, Jipei Liao, Zhenqiu Liu, Feng Jiang · 2014 · Molecular Cancer
40. From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF)
    S. Couraud, Alexis Benjamin Cortot, Laurent Greillier, Valérie Gounant, B. Mennecier, Nicolas Girard, Benjamin Besse, Laurent Brouchet, O. Castelnau, Paul Frappé et al. · 2012 · Annals of Oncology
41. A method to assess image quality for Low-dose PET: analysis of SNR, CNR, bias and image noise
    Jianhua Yan, Joshua D. Schaefferkoetter, Maurizio Conti, David William Townsend · 2016 · Cancer Imaging
42. miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives
    Mateusz Florczuk, Adam Szpechciński, Joanna Chorostowska‐Wynimko · 2017 · Targeted Oncology
43. Shared decision making in preventive health care: What it is; what it is not.
    Roland M Grad, France Légaré, Neil R. Bell, James Arthur Dickinson, Harminder Singh, Moore Ae, Danielle Kasperavicius, Kaylyn L Kretschmer · 2017 · PubMed Central
44. Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer
    Shaohua Lu, Hui Kong, Yingyong Hou, Di Ge, Wei Huang, Jiaxian Ou, Dawei Yang, Li Zhang, Guoming Wu, Yong Song et al. · 2018 · Lung Cancer
45. The biological functions and clinical applications of exosomes in lung cancer
    Rui Chen, Xin Xu, Zijun Qian, Congcong Zhang, Yongjie Niu, Zhixian Wang, Jianli Sun, Xiao Zhang, Yongchun Yu · 2019 · Cellular and Molecular Life Sciences
46. Development and clinical application of deep learning model for lung nodules screening on CT images
    Sijia Cui, Shuai Ming, Yi Lin, Fanghong Chen, Qiang Shen, Hui Li, Gen Chen, Xiangyang Gong, Haochu Wang · 2020 · Scientific Reports
47. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis
    Jennifer M. Yeh, Chin Hur, Zachary J. Ward, Deborah Schrag, Sue J. Goldie · 2015 · Gut
48. Folate Receptor-Positive Circulating Tumor Cells as a Novel Diagnostic Biomarker in Non-Small Cell Lung Cancer
    Yue Yu, Zhaoli Chen, Jingsi Dong, Peng Wei, Rongjun Hu, Chengcheng Zhou, Nan Sun, Mei Luo, Wenjing Yang, Ran Yao et al. · 2013 · Translational Oncology
49. Is Limited Resection Appropriate for Radiologically “Solid” Tumors in Small Lung Cancers?
    Aritoshi Hattori, Kenji Suzuki, Takeshi Matsunaga, Mariko Fukui, Yoshitaka Kitamura, Yoshikazu Miyasaka, Yukio Tsushima, Kazuya Takamochi, Shiaki Oh · 2012 · The Annals of Thoracic Surgery
50. Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules
    Ying Liu, Yoganand Balagurunathan, Thomas Atwater, Sanja Antic, Qian Li, Ronald C. Walker, Gary T. Smith, Pierre P. Massion, Matthew B. Schabath, Robert J. Gillies · 2016 · Clinical Cancer Research
51. Patient-Centered Outcomes among Lung Cancer Screening Recipients with Computed Tomography: A Systematic Review
    Christopher G. Slatore, Donald Richard Sullivan, Miranda Pappas, Linda L. Humphrey · 2014 · Journal of Thoracic Oncology
52. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non–Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B
    William R. Wikoff, Samir Hanash, Brian C. DeFelice, Suzanne Miyamoto, Matt J. Barnett, Yang Zhao, Gary E. Goodman, Ziding Feng, David R. Gandara, Oliver Fiehn et al. · 2015 · Journal of Clinical Oncology
53. Beyond Traditional Newspaper Advertisement: Leveraging Facebook-Targeted Advertisement to Recruit Long-Term Smokers for Research
    Lisa Carter‐Harris, Rebecca J. Bartlett Ellis, Adam Warrick, Susan M. Rawl · 2016 · Journal of Medical Internet Research
54. Risk-Targeted Lung Cancer Screening
    Vaibhav Kumar, Joshua T. Cohen, David V. Klaveren, Djøra I. Soeteman, John B. Wong, Peter J. Neumann, David M. Kent · 2018 · Annals of Internal Medicine
55. Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
    Qixian Yang, Ping Zhang, Rongqiang Wu, Kefeng Lu, Hongxing Zhou · 2018 · Disease Markers
56. Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer
    Chengdi Wang, Yuxuan Wu, Jun Shao, Dan Liu, Weimin Li · 2020 · BMC Cancer
57. Improving Selection Criteria for Lung Cancer Screening. The Potential Role of Emphysema
    Pablo Sánchez-Salcedo, David O. Wilson, Juan Pablo de-Torres, Joel L. Weissfeld, Juan Bertó, Arantza Campo, Ana B. Alcaide, Jesús C. Pueyo, Gorka Bastarrika, Luis Miguel Seijo et al. · 2015 · American Journal of Respiratory and Critical Care Medicine
58. Matched‐pair and propensity score comparisons of outcomes of patients with clinical stage I non–small cell lung cancer treated with resection or stereotactic radiosurgery
    John M. Varlotto, Achilles J. Fakiris, John C. Flíckinger, Laura Nyshel Medford-Davis, Adam L. Liss, Julia Shelkey, Chandra Prakash Belani, Jill Deluca, Abram Recht, Neelabh Maheshwari et al. · 2013 · Cancer
59. Novel Methods of Intraoperative Localization and Margin Assessment of Pulmonary Nodules
    Jane Josephine Keating, Sunil Kumar Singhal · 2016 · Seminars in Thoracic and Cardiovascular Surgery
60. A qualitative study exploring why individuals opt out of lung cancer screening
    Lisa Carter‐Harris, Susan D. Brandzel, Karen J. Wernli, Joshua A. Roth, Diana S.M. Buist · 2016 · Family Practice
61. Lung Cancers Associated with Cystic Airspaces: Underrecognized Features of Early Disease
    Sarah Sheard, Joanna B. Moser, Charlie Sayer, Konstantinos Stefanidis, Anand Devaraj, Ioannis Vlahos · 2018 · Radiographics
62. Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
    Bin Liu, Julio C. Ricarte‐Filho, Apurva Mallisetty, Cassandra Villani, Anastasia E Kottorou, Kristen Rodgers, Chen Chen, Tomoaki Ito, Kyla Holmes, Nicole Gastala et al. · 2020 · Clinical Cancer Research
63. Epidemic of Lung Cancer in Patients With HIV Infection
    Tiffany A. Winstone, S. F. Paul Man, Mark Hull, Julio S. Montaner, Don D. Sin · 2013 · CHEST Journal
64. Early Events in the Molecular Pathogenesis of Lung Cancer
    Humam N. Kadara, Paul A. Scheet, Ignacio Ivan Wistuba, Avrum E. Spira · 2016 · Cancer Prevention Research
65. Deep Learning to Estimate Biological Age From Chest Radiographs
    Raghu, Vineet K., Weiss, Jakob, Hoffmann, Udo, Aerts, Hugo J.W.L., Lu, Michael T. · 2021 · JACC: Cardiovascular Imaging
66. Very Low-Dose (0.15 mGy) Chest CT Protocols Using the COPDGene 2 Test Object and a Third-Generation Dual-Source CT Scanner With Corresponding Third-Generation Iterative Reconstruction Software
    John D. Newell, Matthew K. Fuld, Thomas Allmendinger, Jered Sieren, Kung‐Sik Chan, Junfeng Guo, Eric A. Hoffman · 2014 · Investigative Radiology
67. Cancer Screening Campaigns — Getting Past Uninformative Persuasion
    Steven Woloshin, Lisa M. Schwartz, William C. Black, Barnett S. Kramer · 2012 · New England Journal of Medicine
68. Timely follow‐up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium
    Chyke A. Doubeni, Nicole B. Gabler, Cosette Marie Wheeler, Anne Marie McCarthy, Philip E. Castle, Ethan A. Halm, Mitchell D. Schnall, Celette Sugg Skinner, Anna N.A. Tosteson, Donald L. Weaver et al. · 2018 · CA A Cancer Journal for Clinicians
69. Conquering lung cancer: current status and prospects for the future
    Robert Pirker · 2020 · Pulmonology
70. Understanding barriers to lung cancer screening in primary care
    Julia M. Coughlin, Yanyu Zang, Samantha L. Terranella, Gillian C. Alex, Justin M. Karush, Nicole M. Geissen, Gary W. Chmielewski, Andrew T. Arndt, Michael J. Liptay, Laura J. Zimmermann et al. · 2020 · Journal of Thoracic Disease
71. Engineering synthetic breath biomarkers for respiratory disease
    Leslie W. Chan, Melodi Anahtar, Ta‐Hsuan Ong, Kelsey E. Hern, Roderick Russell Kunz, Sangeeta N. Bhatia · 2020 · Nature Nanotechnology
72. Comparison of inspiratory and expiratory lung and lobe volumes among supine, standing, and sitting positions using conventional and upright CT
    Yoshitake Yamada, Minoru Yamada, Shotaro Chubachi, Yoichi Yokoyama, Shiho Matsuoka, Akiko Tanabe, Yuki Niijima, Mitsuru Murata, Koichi Fukunaga, Masahiro Jinzaki · 2020 · Scientific Reports
73. LNCDS: A 2D-3D cascaded CNN approach for lung nodule classification, detection and segmentation
    Prasad Vilas Dutande, Ujjwal Baid, Sanjay Nilkanth Talbar · 2021 · Biomedical Signal Processing and Control
74. The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice
    Lincoln D. Nadauld, Charles H. McDonnell, Tomasz M. Beer, MC Liu, Eric A. Klein, Andrew G. Hudnut, Richard Whittington, Bruce Taylor, Geoffrey R. Oxnard, Jafi Alyssa Lipson et al. · 2021 · Cancers
75. Vaping, Environmental Toxicants Exposure, and Lung Cancer Risk
    Shaimaa A. Shehata, Eman Ali Toraih, Ezzat A. Ismail, Abeer M. Hagras, Ekramy Mahmoud Elmorsy, Manal Said Fawzy · 2023 · Cancers
76. Promise and pitfalls of quantitative imaging in oncology clinical trials
    Brenda F. Kurland, Elizabeth Robins Gerstner, James M. Mountz, Lawrence Howard Schwartz, Christopher W. Ryan, Michael M. Graham, John Michael Buatti, Fiona M. Fennessy, Edward A. Eikman, Virendra Kumar et al. · 2012 · Magnetic Resonance Imaging
77. Emphysema detected on computed tomography and risk of lung cancer: A systematic review and meta-analysis
    Benjamin M. Smith, Lancelot Pinto, Nicole Ezer, Nicola Sverzellati, Shigeo Muro, Kevin Schwartzman · 2012 · Lung Cancer
78. Cigarette Smoking and Cardiovascular Events
    John William McEvoy, Michael Joseph Blaha, Andrew Paul DeFilippis, João A.C. Lima, David A. Bluemke, William Gregory Hundley, James K. Min, Leslee J. Shaw, Donald M. Lloyd‐Jones, R. Graham Barr et al. · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
79. Electromagnetic navigation bronchoscopy (ENB): Increasing diagnostic yield
    Bernd Lamprecht, Peter Porsch, Birgit Wegleitner, Gertraud Strasser, Bernhard Kaiser, Michael Studnicka · 2012 · Respiratory Medicine
80. MicroRNA as tools and therapeutics in lung cancer
    Jennifer F. Barger, Serge Patrick Nana-Sinkam · 2015 · Respiratory Medicine
81. Defining a Gene Promoter Methylation Signature in Sputum for Lung Cancer Risk Assessment
    Shuguang Leng, Kieu Do, Christin M. Yingling, Maria A. Picchi, Holly J. Wolf, Timothy C. Kennedy, William J. Feser, Anna E. Barón, Wilbur A. Franklin, Malcolm V. Brock et al. · 2012 · Clinical Cancer Research
82. Stereotactic Body Radiation Therapy for Lung Cancer
    Charles B. Simone, Brian Wildt, Andrew R. Haas, Greg Pope, Ramesh Rengan, Stephen M. Hahn · 2013 · CHEST Journal
83. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer
    Pierre P. Massion, Graham F. Healey, Laura J. Peek, Lynn Fredericks, Herb F. Sewell, Andrea Murray, John F.R. Robertson · 2016 · Journal of Thoracic Oncology
84. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation
    Sandra J. Japuntich, Naomi H. Krieger, Abbey L. Salvas, Michael P. Carey · 2017 · Journal of the National Medical Association
85. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results
    Martin Carl Tammemägi, Kevin ten Haaf, Iakovos Toumazis, Chung Yin Kong, Summer S. Han, Jihyoun Jeon, John M. Commins, Thomas Riley, Rafael Meza · 2019 · JAMA Network Open
86. Patterns and Factors Associated With Adherence to Lung Cancer Screening in Diverse Practice Settings
    Lori C. Sakoda, M. Patricia Rivera, Jie Zhang, Pasangi Perera, Cecile A. Laurent, Danielle D. Durham, Roger Huamani, Lindsay M. Lane, Adam Schwartz, Charles P. Quesenberry et al. · 2021 · JAMA Network Open
87. Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis
    Quanyang, Wu, Yao, Huang, Sicong, Wang, Linlin, Qi, Zewei, Zhang, Donghui, Hou, Hongjia, Li, Shijun, Zhao · 2024 · Cancer Medicine
88. Reduced-Dose Low-Voltage Chest CT Angiography with Sinogram-affirmed Iterative Reconstruction versus Standard-Dose Filtered Back Projection
    François Pontana, Julien Pagniez, Alain Duhamel, Thomas G. Flohr, Jean‐Baptiste Faivre, Colm Murphy, Jacques Rémy, Martine Rémy-Jardin · 2013 · Radiology
89. Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer
    Ning Li, Jie Ma, Maria A. Guarnera, Hong‐Bin Fang, Ling Cai, Feng Jiang · 2013 · Journal of Cancer Research and Clinical Oncology
90. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation
    Tristan Snowsill, Huiqin Yang, Edward Griffin, Linda Long, Jo Varley‐Campbell, Helen F. Coelho, Sophie Robinson, Chris Hyde · 2018 · Health Technology Assessment
91. The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art
    François Montagne, Florian Guisier, Nicolas Vénissac, Jean‐Marc Baste · 2021 · Cancers
92. Socio-Economic Inequalities in Lung Cancer Outcomes: An Overview of Systematic Reviews
    Daniel Redondo‐Sánchez, Dafina Petrova, Miguel Rodríguez‐Barranco, Pablo Fernández‐Navarro, José Juan Jiménez‐Moleón, María‐José Sánchez · 2022 · Cancers
93. Data-driven risk stratification and precision management of pulmonary nodules detected on chest computed tomography
    Chengdi Wang, Jun Shao, Yichu He, Jiaojiao Wu, Xingting Liu, Liuqing Yang, Ying Wei, Xiang Sean Zhou, Yiqiang Zhan, Feng Shi et al. · 2024 · Nature Medicine
94. Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
    Daniel C. Bruhm, Nicholas A. Vulpescu, Zachariah H. Foda, Jillian A. Phallen, Robert B. Scharpf, Victor E. Velculescu · 2025 · Nature reviews. Cancer
95. Residential Segregation and Lung Cancer Mortality in the United States
    Awori Jeremiah Hayanga, Steve B. Zeliadt, Leah Monique Backhus · 2013 · JAMA Surgery
96. Doubling Times and CT Screen–Detected Lung Cancers in the Pittsburgh Lung Screening Study
    David O. Wilson, Adam Ryan, Carl R. Fuhrman, Matthew J. Schuchert, Steven David Shapiro, Jill M. Siegfried, Joel L. Weissfeld · 2011 · American Journal of Respiratory and Critical Care Medicine
97. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort
    Kuanrong Li, Anika Hüsing, Disorn Sookthai, Manuela M. Bergmann, Heiner Boeing, Nikolaus Becker, Rudolf Kaaks · 2015 · Cancer Prevention Research
98. Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population
    Kristine Højgaard Allin, Stig E. Bojesen, Børge Grønne Nordestgaard · 2016 · International Journal of Cancer
99. CT screening for lung cancer: Importance of emphysema for never smokers and smokers
    Claudia I. Henschke, Rowena Yip, Paolo Boffetta, Steven B. Markowitz, Albert Miller, Takaomi Hanaoka, Ning Wu, Javier J. Zulueta, David F. Yankelevitz · 2015 · Lung Cancer
100. National Lung Screening Trial Findings by Age: Medicare-Eligible Versus Under-65 Population
     Paul F. Pinsky, David S. Gierada, William Gray Hocking, Edward F. Patz, Barnett S. Kramer · 2014 · Annals of Internal Medicine